Published in Chest on May 01, 2007
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull (2011) 4.27
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun (2009) 3.00
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
Adverse oral health and cognitive decline: the health, aging and body composition study. J Am Geriatr Soc (2013) 2.27
So depression is an inflammatory disease, but where does the inflammation come from? BMC Med (2013) 2.02
Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III. J Neurol Neurosurg Psychiatry (2009) 1.97
Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. Pediatrics (2010) 1.90
Telomere length, current perceived stress, and urinary stress hormones in women. Cancer Epidemiol Biomarkers Prev (2009) 1.88
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology (2009) 1.87
Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep (2009) 1.76
C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int J Clin Pract (2009) 1.66
Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm (2011) 1.64
Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer (2010) 1.61
Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat (2008) 1.60
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One (2009) 1.53
Immunity, atherosclerosis and cardiovascular disease. BMC Med (2013) 1.49
Risk factors for tuberculosis. Pulm Med (2013) 1.48
Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat Res (2011) 1.44
Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care (2011) 1.42
Smoking, Smoking Cessation, and the Risk of Type 2 Diabetes among Japanese Adults: Japan Epidemiology Collaboration on Occupational Health Study. PLoS One (2015) 1.40
Human pathogens abundant in the bacterial metagenome of cigarettes. Environ Health Perspect (2009) 1.31
TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag (2008) 1.31
Heart disease is common in humans and chimpanzees, but is caused by different pathological processes. Evol Appl (2009) 1.22
A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke (2009) 1.20
Association of C-reactive protein with cognitive impairment. Arch Neurol (2010) 1.19
Energy intake and leukocyte telomere length in young adults. Am J Clin Nutr (2012) 1.18
Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry (2014) 1.18
Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. PLoS One (2013) 1.15
Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (2009) 1.10
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol (2012) 1.09
Association between optimism and serum antioxidants in the midlife in the United States study. Psychosom Med (2012) 1.08
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A (2009) 1.05
Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.04
High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function. Am J Physiol Lung Cell Mol Physiol (2008) 1.04
Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans. Am J Transl Res (2013) 1.03
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med (2013) 1.03
Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One (2008) 1.03
Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation. PLoS One (2009) 1.02
Association of the sirtuin and mitochondrial uncoupling protein genes with carotid plaque. PLoS One (2011) 1.00
Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis. Biol Psychiatry (2015) 0.98
Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med (2013) 0.98
Smoking and age-related macular degeneration: review and update. J Ophthalmol (2013) 0.97
Pleiotropic benefit of monomeric and oligomeric flavanols on vascular health--a randomized controlled clinical pilot study. PLoS One (2011) 0.97
Cigarette smoke, bacteria, mold, microbial toxins, and chronic lung inflammation. J Oncol (2011) 0.95
Fruit and vegetable intakes are associated with lower risk of bladder cancer among women in the Multiethnic Cohort Study. J Nutr (2013) 0.95
Immune mechanisms in atherosclerosis, especially in diabetes type 2. Front Endocrinol (Lausanne) (2013) 0.94
Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) (2015) 0.94
Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurol (2010) 0.93
Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol (2012) 0.93
The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin-low-density lipoprotein. Heart Vessels (2014) 0.93
Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase. Am J Physiol Lung Cell Mol Physiol (2011) 0.93
Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc (2014) 0.93
Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.92
Target population for clinical trials on sarcopenia. J Nutr Health Aging (2008) 0.92
Lifestyle factors and inflammation: associations by body mass index. PLoS One (2013) 0.92
Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res (2009) 0.92
Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol (2010) 0.90
Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration. Mutat Res (2008) 0.89
Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLoS One (2014) 0.89
Smoking decreases the level of circulating CD34+ progenitor cells in young healthy women--a pilot study. BMC Womens Health (2010) 0.88
C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations. Inflammation (2013) 0.88
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors. Acta Orthop (2011) 0.88
The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis. Arthritis Res Ther (2012) 0.87
Influence of Smoking Consumption and Nicotine Dependence Degree in Cardiac Autonomic Modulation. Arq Bras Cardiol (2016) 0.87
Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.85
Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort. Lupus (2009) 0.85
Inequity in colorectal cancer treatment and outcomes: a population-based study. Br J Cancer (2008) 0.85
Work engagement and high-sensitivity C-reactive protein levels among Japanese workers: a 1-year prospective cohort study. Int Arch Occup Environ Health (2014) 0.84
Noni juice reduces lipid peroxidation-derived DNA adducts in heavy smokers. Food Sci Nutr (2013) 0.84
Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study. BMC Geriatr (2013) 0.83
Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World J Surg Oncol (2014) 0.83
Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer. Int J Clin Oncol (2011) 0.83
Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis (2009) 0.83
Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.83
Smoking and body fat mass in relation to bone mineral density and hip fracture: the Hordaland Health Study. PLoS One (2014) 0.83
Serum oxidative stress-induced repression of Nrf2 and GSH depletion: a mechanism potentially involved in endothelial dysfunction of young smokers. PLoS One (2012) 0.82
C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. Drug Alcohol Depend (2013) 0.82
Fruits, vegetables, and bladder cancer risk: a systematic review and meta-analysis. Cancer Med (2014) 0.82
Smoking Status Effect on Inflammatory Markers in a Randomized Trial of Current and Former Heavy Smokers. Int J Inflam (2015) 0.81
Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2? PLoS One (2013) 0.81
Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation. Nutr J (2013) 0.81
Do all roads lead to Rome? The role of neuro-immune interactions before birth in the programming of offspring obesity. Front Neurosci (2015) 0.81
Association of smoking and other risk factors with Fuchs' endothelial corneal dystrophy severity and corneal thickness. Invest Ophthalmol Vis Sci (2013) 0.81
Susceptibility of the aging lung to environmental injury. Semin Respir Crit Care Med (2010) 0.81
Prevalence of cardiovascular disease in subjects hospitalized due to chronic obstructive pulmonary disease in Beijing from 2000 to 2010. J Geriatr Cardiol (2012) 0.81
Circulating oxidized low-density lipoproteins are associated with overweight, obesity, and low serum carotenoids in older community-dwelling women. Nutrition (2008) 0.81
Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women. J Womens Health (Larchmt) (2011) 0.81
Cigarette smoking and self-assessed upper airway health. Eur Arch Otorhinolaryngol (2010) 0.81
Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. Respir Res (2012) 0.81
Current cigarette smoking is a reversible cause of elevated white blood cell count: Cross-sectional and longitudinal studies. Prev Med Rep (2016) 0.80
Effects of age and smoking on endothelial function assessed by quantitative cardiovascular magnetic resonance in the peripheral and central vasculature. J Cardiovasc Magn Reson (2015) 0.80
Effect of gene environment interactions on lung function and cardiovascular disease in COPD. Int J Chron Obstruct Pulmon Dis (2011) 0.80
Influence of smoking on perioperative oxidative stress after pulmonary resection. Surg Today (2015) 0.80
Lifetime Smoking History and Cause-Specific Mortality in a Cohort Study with 43 Years of Follow-Up. PLoS One (2016) 0.79
Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia. Front Physiol (2015) 0.79
High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population. Int J Angiol (2011) 0.79
Preoperative serum oxidative stress marker as a strong indicator of nodal involvement in clinical stage I lung adenocarcinoma. Int J Clin Oncol (2011) 0.79
Influence of hypertension, obesity and nicotine abuse on quantitative and qualitative changes in acute-phase proteins in patients with essential hypertension. Med Sci Monit (2012) 0.79
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med (2014) 6.29
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 3.54
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest (2003) 2.90
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med (2010) 2.80
Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A (2006) 2.51
Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med (2002) 2.32
Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest (2014) 2.27
Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J (2013) 2.20
Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A (2004) 2.19
Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest (2004) 2.08
Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer (2006) 2.07
Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation. Eur Respir J (2013) 2.05
Inaccuracy of estimating peak work rate from six-minute walk distance in patients with COPD. COPD (2012) 1.98
COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J (2005) 1.87
Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.79
Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.76
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc (2015) 1.72
Interactive effect of family history and environmental factors on respiratory tract-related morbidity in infancy. J Allergy Clin Immunol (2007) 1.71
Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology. Am J Respir Cell Mol Biol (2002) 1.71
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition (2003) 1.60
Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone (2012) 1.56
Proposal for a multidimensional staging system for chronic obstructive pulmonary disease. Respir Med (2005) 1.54
Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases. Pulm Pharmacol Ther (2013) 1.54
Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J (2004) 1.53
Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD. Respir Med (2009) 1.49
The role of leptin in the development of pulmonary neutrophilia in infection and acute lung injury. Crit Care Med (2014) 1.49
Prevention of asthma in genetically susceptible children: a multifaceted intervention trial focussed on feasibility in general practice. Pediatr Allergy Immunol (2011) 1.42
Relationship between radical generation by urban ambient particulate matter and pulmonary function of school children. J Toxicol Environ Health A (2006) 1.41
The last wish of a patient with end stage chronic obstructive pulmonary disease. BMJ (2008) 1.41
Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax (2007) 1.32
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med (2010) 1.30
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc (2011) 1.28
In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta (2006) 1.27
The impact of a primary care physician cooperative on the caseload of an emergency department: the Maastricht integrated out-of-hours service. J Gen Intern Med (2005) 1.26
Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol (2006) 1.25
Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc (2007) 1.23
Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med (2011) 1.23
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med (2014) 1.20
Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax (2013) 1.20
Systemic effects in COPD. Chest (2002) 1.19
Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol (2002) 1.19
Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med (2003) 1.17
Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation. Am J Physiol Cell Physiol (2005) 1.17
Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.16
Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. Cancer Epidemiol Biomarkers Prev (2002) 1.16
Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD (2006) 1.15
Out-of-hours primary care. Implications of organisation on costs. BMC Fam Pract (2006) 1.13
Increased systemic inflammation is a risk factor for COPD exacerbations. Chest (2008) 1.12
Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc (2009) 1.12
Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest (2003) 1.12
Integration of pulmonary rehabilitation in COPD. Lancet (2008) 1.11
Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res (2010) 1.11
Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann Med (2012) 1.09
Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis (2010) 1.08
Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med (2010) 1.07
The metabolic response during resistance training and neuromuscular electrical stimulation (NMES) in patients with COPD, a pilot study. Respir Med (2008) 1.06
IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet (2009) 1.06
Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med (2011) 1.05
Dyspnea in elderly family practice patients. Occurrence, severity, quality of life and mortality over an 8-year period. Fam Pract (2005) 1.04
Differences in walking pattern during 6-min walk test between patients with COPD and healthy subjects. PLoS One (2012) 1.04
Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production. J Immunol (2009) 1.04
Effect of 'activity monitor-based' counseling on physical activity and health-related outcomes in patients with chronic diseases: A systematic review and meta-analysis. Ann Med (2013) 1.04
Gender differences in the adipose secretome system in chronic obstructive pulmonary disease (COPD): a pivotal role of leptin. Respir Med (2011) 1.03
A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest (2003) 1.03
Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice. J Immunol (2010) 1.03
Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr (2002) 1.02
Task-related oxygen uptake during domestic activities of daily life in patients with COPD and healthy elderly subjects. Chest (2011) 1.02
α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest (2010) 1.02
Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respir Med (2009) 1.02
Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol (2006) 1.01
Supplementation of soy protein with branched-chain amino acids alters protein metabolism in healthy elderly and even more in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2007) 1.00
Enhanced deposition of low-molecular-weight hyaluronan in lungs of cigarette smoke-exposed mice. Am J Respir Cell Mol Biol (2009) 1.00
Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. Am J Respir Cell Mol Biol (2008) 1.00
Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism. Am J Clin Nutr (2005) 1.00
Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training. Med Sci Sports Exerc (2005) 1.00
Silica induces NLRP3 inflammasome activation in human lung epithelial cells. Part Fibre Toxicol (2013) 1.00
Quantitative CT: Associations between Emphysema, Airway Wall Thickness and Body Composition in COPD. Pulm Med (2011) 0.99
Follow-up care by patient's own general practitioner after contact with out-of-hours care. A descriptive study. BMC Fam Pract (2005) 0.99
Objective physical activity assessment in patients with chronic organ failure: a validation study of a new single-unit activity monitor. Arch Phys Med Rehabil (2011) 0.99
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration (2008) 0.99
Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem Pharmacol (2006) 0.98
Differences in gene expression and cytokine production by crystalline vs. amorphous silica in human lung epithelial cells. Part Fibre Toxicol (2012) 0.98
New normative values for handgrip strength: results from the UK Biobank. J Am Med Dir Assoc (2013) 0.98
Problematic activities of daily life are weakly associated with clinical characteristics in COPD. J Am Med Dir Assoc (2011) 0.98
Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J Nutr (2007) 0.97
Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking. Psychosom Med (2004) 0.97